Group L received trigger point injection with a 3.2 ml of a 1:1 mixture of 1% lidocaine and 0.9% normal saline

Group H received trigger point injection with the same volume of solution supplemented with hyaluronidase (H-LASE®, 1500 iu, L&H Pharm., Seoul, Korea) 600 iu/ml

Myofascial Pain Syndrome

trigger point injection

Hyaluronidase for Trigger Point Injection in Myofascial Pain Syndrome

Effect of Hyaluronidase Addition to Lidocaine for Trigger Point Injection in Myofascial Pain Syndrome

Ji Won Choi

clinical fellowship

Samsung Medical Center

Myofacial Pain Syndromes

An infrared (the low-level laser, class IIIb) gallium aluminum arsenide (Ga-Al-As) diode laser device (MediUm-TECH Medizingeräte GmbH, Germany) with a wavelength of 810nm and a maximum power output of 150mW in the continuous wave mode

low-level laser therapy

Chang Gung Memorial Hospital

The Efficacy of Low-level Laser on Cervical Myofascial Pain Syndrome

Is Low-level Laser on Traditional Acupoint as Effective as That on Trigger Point in the Management of Cervical Myofascial Pain Syndrome?

myofascial pain syndromes/edema

Hyaluronidase for Trigger Point Injection in Myofascial Pain Syndrome

The Efficacy of Low-level Laser on Cervical Myofascial Pain Syndrome

Baza e të dhënave më e plotë e bimëve medicinale e mbështetur nga shkenca